These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23979375)

  • 21. The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) adrenergic receptor antagonist esmolol in healthy individuals.
    Muszkat M; Hoofien A; Orlanski-Meyer E; Makhoul H; Porat E; Davidson EM; Blotnick S; Caraco Y
    Pharmacogenet Genomics; 2013 Jan; 23(1):25-8. PubMed ID: 23114278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esmolol for septic shock: more than just heart rate control?
    Orbegozo Cortes D; Njimi H; Dell'Anna AM; Taccone FS
    Minerva Anestesiol; 2014 Feb; 80(2):254-8. PubMed ID: 24500140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of esmolol on septic shock and sepsis: A meta-analysis of randomized controlled studies.
    Liu P; Wu Q; Tang Y; Zhou Z; Feng M
    Am J Emerg Med; 2018 Mar; 36(3):470-474. PubMed ID: 29269160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock.
    Du W; Wang XT; Long Y; Liu DW
    Chin Med J (Engl); 2016 Jul; 129(14):1658-65. PubMed ID: 27411452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of β₁-, β₂- and β₃-adrenoceptors in the temporomandibular joint induces antinociception especially in female rats.
    Fávaro-Moreira NC; Parada CA; Tambeli CH
    Eur J Pain; 2012 Oct; 16(9):1302-10. PubMed ID: 22438216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infusion of esmolol attenuates lipopolysaccharide-induced myocardial dysfunction.
    Wang Z; Wu Q; Nie X; Guo J; Yang C
    J Surg Res; 2016 Jan; 200(1):283-9. PubMed ID: 26316443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
    Albrecht M; Haustein KO
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis.
    Gore DC; Wolfe RR
    Surgery; 2006 May; 139(5):686-94. PubMed ID: 16701103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recruitment of functionally active heart beta2-adrenoceptors in the initial phase of endotoxic shock in pithed rats.
    Godlewski G; Schlicker E; Baranowska U; Malinowska B
    Shock; 2006 Nov; 26(5):510-5. PubMed ID: 17047523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. A letter to the authors.
    Zante B; Wirtz S
    Wien Klin Wochenschr; 2013 Jan; 125(1-2):54-5. PubMed ID: 23224411
    [No Abstract]   [Full Text] [Related]  

  • 31. Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: a randomised controlled pilot study.
    van der Voort PH; van Zanten M; Bosman RJ; van Stijn I; Wester JP; van Raalte R; Oudemans-van Straaten HM; Zandstra DF
    Eur J Anaesthesiol; 2015 Mar; 32(3):189-98. PubMed ID: 25032942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-blocker use in severe sepsis and septic shock: a systematic review.
    Sanfilippo F; Santonocito C; Morelli A; Foex P
    Curr Med Res Opin; 2015; 31(10):1817-25. PubMed ID: 26121122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Reply to a letter to the authors.
    Balik M; Rulisek J; Leden P; Zakharchenko M; Otahal M; Bartakova H; Korinek J
    Wien Klin Wochenschr; 2014 Apr; 126(7-8):246-7. PubMed ID: 24343046
    [No Abstract]   [Full Text] [Related]  

  • 34. Gut mucosal permeability, β1 receptor blockers and gastric tonometry: the time is now!
    Gutierrez G; Ballarino G
    Intensive Care Med; 2011 Nov; 37(11):1721-2. PubMed ID: 21847650
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of the β-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study].
    Yang S; Liu Z; Yang W; Zhang G; Hou B; Liu J; Shi Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct; 26(10):714-7. PubMed ID: 25315942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.
    Wang Z; Wu Q; Nie X; Guo J; Yang C
    Clin Drug Investig; 2015 Nov; 35(11):707-16. PubMed ID: 26387030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardio-protection afforded by β-blockade is maintained during resistance exercise.
    Conviser JM; Ng AV; Rockey SS; Thomas DP
    J Sci Med Sport; 2017 Feb; 20(2):196-201. PubMed ID: 27012728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The microcirculatory dynamics of prostaglandin E1 and/or nicardipine and their different reactions in the hyper- and hypodynamic state of septic shock in a rat model].
    Takakura K; Sugiura Y; Nakajima K; Goto Y
    Kokyu To Junkan; 1993 Mar; 41(3):249-53. PubMed ID: 8469831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of Esmolol on Tissue Perfusion and Clinical Prognosis of Patients with Severe Sepsis: A Prospective Cohort Study.
    Shang X; Wang K; Xu J; Gong S; Ye Y; Chen K; Lian F; Chen W; Yu R
    Biomed Res Int; 2016; 2016():1038034. PubMed ID: 27652257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Causative factors of esmolol-induced reduction in arterial blood pressure differ in accordance with its doses].
    Fujiwara K; Miasuda R; Takeda S
    Masui; 2011 Mar; 60(3):353-60. PubMed ID: 21485106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.